Death, Sudden
6
1
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Prognosis Impact of NSVTs After an AMI (TeVeO Study).
Critical Health Assessment and Outcomes Score/Study
Drug-induced Repolarization ECG Changes
Decision Support for Adults Facing Implantable Cardioverter-Defibrillator Pulse Generator Replacement
The Effects of Enzymes and Flavonoids on Inflammation and Coagulation After Marathon
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm